Acral lentiginous melanoma: A rare variant
with unique diagnostic challenges
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Introduction
•

Acral lentiginous melanoma (ALM), named for its
location and histological growth pattern, is a rare variant
of melanoma. ALM presents on palms, soles, or in
association with the nail unit.1 While ALM accounts for
approximately 5% of melanomas diagnosed each year,
it is the most commonly diagnosed subtype of
melanoma in non-Caucasian patients.
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Diagnosis and Treatment
•

Histopathology: Multiple shave biopsies were
performed to remove all clinical pigment; pathology
revealed extensive proliferation of malignant
melanocytes in a lentiginous, nested and pagetoid array
consistent with malignant melanoma in situ, acral
lentiginous type (Figure B).

Case Presentation
•

•
•

HPI: A 72-year-old, Fitzpatrick skin type (FST) 5 female
presented with concern of an enlarging dark spot on the
plantar surface of her right foot. She stated she first
noticed the lesion ten years ago, but that it had been
rapidly enlarging and darkening for the past 3 years.
Patient denied pain, pruritus, or any other symptoms
associated with the lesion. She also denied systemic
symptoms including fevers, chills, unintentional weight
loss, cough and headache.
PMHx: diabetes mellitus II, essential hypertension
Physical exam: 3 x 1.5 centimeter poorly demarcated,
brown to black patch with two adjacent smaller brown to
black patches, all with scalloped borders, were noted on
the right plantar surface (Figure A).

•

Treatment: Patient underwent wide local excision,
under general anesthesia, to the level of underlying
fascia with 1 cm margins. An acellular allograft dermal
matrix was utilized to close the defect created by lesion
removal. Surgical margins were negative for residual
acral lentiginous melanoma. No further treatment was
required. Patient was instructed to follow with
dermatology for full body skin exams every 3 months.

Discussion
•

While the incidence of ALM is similar in all racial and
ethnic groups, ALM represents a disproportionate
percentage of melanomas in darker skinned individuals.
This may be due to unique pathophysiology of ALM as
these lesions often develop on sun protected areas, in
contrast to other forms of melanoma, in which UVB
exposure is a well-known risk factor for development.1

•

While available treatment options for cutaneous
melanomas continue to improve, plantar melanomas,
the most common site of involvement in non-Caucasian
patients, are often associated with a poor prognosis.2

•

While the explanation for this is likely multi-factorial, one
important factor is that non-Caucasian ethnic groups
tend to present with more advanced tumors than
Caucasian patients.2 Reasons for this may include less
access to preventative screenings and a misconception
that darker races do not develop skin cancer.2

•

Current public health education programs for skin
cancer are directed towards Caucasian patients,
specifically high-risk individuals with fair skin and light
eyes.2 Physician training, patient education and public
awareness campaigns directed toward all ethnic groups
may decrease time to diagnosis for ALM and, therefore,
lead to more favorable prognosis.
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